Mixed news from the CLL-VR study into SARS-Cov... - CLL Support
Mixed news from the CLL-VR study into SARS-Cov-2 vaccination in chronic lymphocytic leukemia
You need to be a member of this community to see this post.
Read more about...
30 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
This post, prepared in collaboration with @[52122] , draws together some earlier posts...
Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
Today, the Doherty Institute in Melbourne, Australia, released a statement about a research study...
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
For more than a year we have been reminding each other that even if we don't produce antibodies in...
T-cell /Cellular Immune Responses in Patients with CLL from the Pfizer-BioNTech COVID-19 Vaccine (BNT162b mRNA Covid19 Vaccine)
From Dr Tamar Tadmor, Head of the Israeli CLL study group at iwCLL.
Patients with CLL suffer from...
VACCINATIONS FOR PEOPLE WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL/SLL)
This pinned post replaces our earlier reference post about vaccinations for those with CLL/SLL. It...
Related Posts
LLS Covid-19 Vaccine Trial: Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Living in the USA with CLL and want to know where to sign up for your COVID-19 Vaccination? A State-by-State List- "Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lym- Acalabrutinib Plus Venetoclax and Obinutuzumab Achieves High Bone Marrow uMRD Rate in Chronic Lymphocytic Leukemia - CLL
